Prognostic Value of Tumor Length for Cause-Specific Death in Resectable Esophageal Cancer
- PMID: 29883640
- DOI: 10.1016/j.athoracsur.2018.05.018
Prognostic Value of Tumor Length for Cause-Specific Death in Resectable Esophageal Cancer
Abstract
Background: The current esophageal cancer American Joint Committee on Cancer TNM staging system may not capture the full prognostic implications of the primary tumor. A study is needed to explore the prognostic value of tumor size on esophageal cancer-specific death.
Methods: Patients who underwent surgical resection for non-metastatic esophageal cancer were selected from the Surveillance, Epidemiology and End Results Program database (United States, 1988 to 2014). With the use of statistics methods, maximally selected rank and two hazard models (Cox model and Fine-Gray model), the optimum cutoff point for tumor length in each T classification was estimated and the prognostic value of tumor size on esophageal cancer-specific death was analyzed.
Results: A total of 4,447 patients were identified. The median tumor size was significantly correlated with T classification, with the correlation coefficient of 0.43 (p < 0.001). Patients in the T1 to T3 classifications who had larger tumor size showed a larger probability of cancer-specific death. The multivariate Cox model showed that tumor size was significantly associated with an increase in cancer-specific death in T1 (2.15, 95% confidence interval [CI]: 1.72 to 2.69) and T2 (1.31, 95% CI: 1.06 to 1.62) but was marginally significantly associated in T3 (1.12, 95% CI: 1.00 to 1.27) and insignificantly associated in T4 classification (p > 0.1). Similar results were found by using the multivariate Fine-Gray model.
Conclusions: We have found that combining T classification with tumor size can increase the precision in identifying the high-risk groups in T1 to T2 classifications. On the basis of esophageal cancer-specific death our study explores the prognostic cutoff point of tumor size by T classification.
Copyright © 2018 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.World J Gastroenterol. 2014 Dec 28;20(48):18397-403. doi: 10.3748/wjg.v20.i48.18397. World J Gastroenterol. 2014. PMID: 25561808 Free PMC article.
-
Comparison of the 7th and proposed 8th editions of the AJCC/UICC TNM staging system for esophageal squamous cell carcinoma underwent radical surgery.Eur J Surg Oncol. 2017 Oct;43(10):1949-1955. doi: 10.1016/j.ejso.2017.06.005. Epub 2017 Jun 23. Eur J Surg Oncol. 2017. PMID: 28716377
-
Impact of postoperative radiation after esophagectomy for esophageal cancer.J Thorac Oncol. 2010 Feb;5(2):244-50. doi: 10.1097/JTO.0b013e3181c5e34f. J Thorac Oncol. 2010. PMID: 20009774
-
Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.Cancer. 2008 Mar 15;112(6):1239-46. doi: 10.1002/cncr.23309. Cancer. 2008. PMID: 18224663
-
[Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].Zhonghua Zhong Liu Za Zhi. 2009 Jul;31(7):541-5. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19950705 Chinese.
Cited by
-
Tumor size as a significant prognostic factor in T1 gastric cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis.BMC Gastroenterol. 2023 Apr 12;23(1):121. doi: 10.1186/s12876-023-02737-z. BMC Gastroenterol. 2023. PMID: 37046218 Free PMC article.
-
Risk factors for distant metastasis and prognosis in stage T1 esophageal cancer: A population-based study.Front Surg. 2023 Jan 6;9:988460. doi: 10.3389/fsurg.2022.988460. eCollection 2022. Front Surg. 2023. PMID: 36684271 Free PMC article.
-
Effect of the Age-Adjusted Charlson Comorbidity Index on the Survival of Esophageal Squamous Cell Carcinoma Patients after Radical Esophagectomy.J Clin Med. 2022 Nov 14;11(22):6737. doi: 10.3390/jcm11226737. J Clin Med. 2022. PMID: 36431214 Free PMC article.
-
A Novel Model Combining Tumor Length, Tumor Thickness, TNM_Stage, Nutritional Index, and Inflammatory Index Might Be Superior to the 8th TNM Staging Criteria in Predicting the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated With Definitive Chemoradiotherapy.Front Oncol. 2022 Jun 1;12:896788. doi: 10.3389/fonc.2022.896788. eCollection 2022. Front Oncol. 2022. PMID: 35719969 Free PMC article.
-
A Clinical Scoring Model to Predict the Effect of Induction Chemotherapy With Definitive Concurrent Chemoradiotherapy on Esophageal Squamous Cell Carcinoma Prognosis.Front Oncol. 2021 Nov 29;11:703074. doi: 10.3389/fonc.2021.703074. eCollection 2021. Front Oncol. 2021. PMID: 34912702 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
